News

IPRF template for summary information for biosimilar reviews

Published on 2016/11/18

The Biosimilars Working Group (BWG) of the International Pharmaceutical Regulators Forum (IPRF) has released a template for Public Assessment Summary Information for Biosimilar (PASIB). T...

17 views

Read more →

Epoetin alfa biosimilar effective in treating anaemia

Published on 2016/11/16

Authors of a post-marketing study of the epoetin alfa biosimilar Retacrit say that the biosimilar is effective and well tolerated in treating chemotherapy-induced anaemia (CIA) [1]. Epoet...

26 views

Read more →

Impact of breast cancer generics in Europe

Published on 2016/11/14

Breast cancer generics can increase patient adherence and reduce healthcare budgets for European countries, according to a report by the Germany-based Institute for Healthcare and Social Research ...

65 views

Read more →

Biosimilars: a new challenge in the current pharmacology

Published on 2016/11/11

In a review of biosimilars in rheumatology author José M Serra López-Matencio and colleagues from the Universidad Autónoma, Madrid, Spain discuss issues surrounding biosimilars*. The b...

20 views

Read more →

Costs and prices of entecavir to treat Hepatitis B

Published on 2016/11/09

In an analysis of the costs and target prices of Hepatitis B treatment entecavir, author Andrew Hill from Liverpool University, UK and colleagues from Imperial College London, UK and Howard Univer...

72 views

Read more →

Pharmacovigilance for mAbs

Published on 2016/11/07

Professor Pierre Michetti, a gastroenterologist at the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland in his paper discusses questions related to monoclonal antibody (mAb) biosimi...

21 views

Read more →

US doctors poised to prescribe biosimilars

Published on 2016/11/04

A survey of specialists in the US has found that nearly half of them expect to prescribe biosimilars to treatment-naïve patients. The survey by healthcare market research company InCrowd...

25 views

Read more →

Extrapolation of indications for mAbs

Published on 2016/11/02

Monoclonal antibody (mAb) biosimilars have recently entered the market, raising questions in the healthcare community. One of the questions discussed by Professor Pierre Michetti, a gastroenterolo...

19 views

Read more →

Impact of hypertension generics in Europe

Published on 2016/10/28

A report by the Germany-based Institute for Healthcare and Social Research (IGES) released in November 2015 found that generics of drugs to treat high blood pressure can increase patient adherence...

51 views

Read more →

Beyond biosimilarity

Published on 2016/10/26

The advent of monoclonal antibody (mAb) biosimilars has raised a series of questions in the healthcare community. Just a few of these questions were discussed by Professor Pierre Michetti, a gastr...

22 views

Read more →

Perception and knowledge of generics in Portugal

Published on 2016/10/24

Patients in Portugal are misinformed about generics, according to researchers from the Bragança Polytechnic Institute [1]. The study by Maria Ribeiro and co-authors analysed the percepti...

17 views

Read more →

Efficacy and safety of biosimilar infliximab compared to other biologicals in rheumatoid arthritis

Published on 2016/10/21

In the paper by Baji et al. [1], the authors carried out a meta-analysis to compare the efficacy and safety of biosimilar infliximab and other available biologicals for the treatment of rheumatoid...

47 views

Read more →